Custom service

Fluorescence and Dye Labeling Peptides

Label peptides with fam, cy, irdye, tamra or custom fluorophores

Turnaround: 2–4 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: N-terminal and side-chain dye attachment; FRET donor–acceptor pair design; dark-quencher pairing for probe assays

Teams come to this service when they need to label peptides with FAM, Cy, IRDye, TAMRA or custom fluorophores. We typically start from N-terminal and side-chain dye attachment, add FRET donor–acceptor pair design where the application demands it, and close the loop with dark-quencher pairing for probe assays so the final labeled peptide with dye-ratio and spectral QC behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 2–4 weeks timeline holds in practice.

FRET substrates for protease assays

Cell-imaging and uptake tracers

Labels requiring photosafety-specialized handling

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • N-terminal and side-chain dye attachment as the default route, with FRET donor–acceptor pair design held as a proven fallback
  • Dark-quencher pairing for probe assays worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Labeled peptide with dye-ratio and spectral QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — N-terminal and side-chain dye attachment, FRET donor–acceptor pair design — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Labeled peptide with dye-ratio and spectral QC is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
2–4 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
N-terminal and side-chain dye attachment; FRET donor–acceptor pair design; dark-quencher pairing for probe assays
Deliverable
Labeled peptide with dye-ratio and spectral QC
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.